Large-scale testing (Phase 3)Study completedNCT00777803
What this trial is testing
NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 381